Japan

Chasing Astellas and Mitsubishi, GSK files for Japanese approval of oral anemia drug
Chasing Astellas and Mitsubishi, GSK files for Japanese approval of oral anemia drug
Fierce Biotech
GSK
Japan
renal anemia
daprodustat
Flag link:
Astellas tests gamification ideas with Japanese universities
Astellas tests gamification ideas with Japanese universities
Pharmaforum
Astellas
Japan
gamification
Flag link:
Look out, Bayer: Roche scores first global nod for targeted cancer drug Rozlytrek
Look out, Bayer: Roche scores first global nod for targeted cancer drug Rozlytrek
Fierce Pharma
Roche
Rozlytrek
Japan
cancer
Bayer Vitrakvi
Flag link:
Daiichi Sankyo comes up way short of promised avian flu vaccine production
Daiichi Sankyo comes up way short of promised avian flu vaccine production
Fierce Pharma
Daiichi Sankyo
vaccines
Japan
avian flu
drug shortages
Flag link:
Roche's Chugai to set up new $1B+ lab in Yokohama, consolidating R&D
Roche's Chugai to set up new $1B+ lab in Yokohama, consolidating R&D
Endpoints
Chugai
Roche
Japan
R&D
Flag link:
Novartis takes another step forward in global Kymriah rollout as Japan OKs the drug at $305K
Novartis takes another step forward in global Kymriah rollout as Japan OKs the drug at $305K
Endpoints
Novartis
Kymriah
Japan
CAR-T
Flag link:
Here's Why Athersys Is Soaring Today
Here's Why Athersys Is Soaring Today
Motley Fool
Athersys
Japan
clinical trials
stem cells
MultiStem
ARDS
Flag link:
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Flag link:
AbbVie gets its first approval for a drug execs believe could be worth up to $5B in annual sales
AbbVie gets its first approval for a drug execs believe could be worth up to $5B in annual sales
Endpoints
AbbVie
Japan
psoriasis
risankizumab
Skyrizi
Flag link:
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval
AbbVie's immunology blockbuster-to-be Skyrizi picks up first global approval
Fierce Pharma
AbbVie
Japan
Skyrizi
psoriasis
psoriatic arthritis
Flag link:
Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan
Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan
Yahoo/Zacks.com
Aerie Pharmaceuticals
clinical trials
Japan
Open-Angle Glaucoma
Flag link:
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business
Yahoo/Reuters
Fujifilm
Biogen
M&A
Japan
biologics
Flag link:
Bayer files prostate cancer drug darolutamide in Japan
Bayer files prostate cancer drug darolutamide in Japan
Pharmaforum
Bayer
prostate cancer
darolutamide
Japan
JNJ
Pfizer
Astellas
Flag link:
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
Japan's Love for Genentech’s Xofluza Flu Treatment May Be Waning
BioSpace
Xofluza
Japan
Genentech
Flag link:
PhRMA urges USTR to address Japan's 'damaging' pricing policy, commends China's progress
PhRMA urges USTR to address Japan's 'damaging' pricing policy, commends China's progress
BioCentury
PhRMA
Japan
China
Flag link:
Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO
Takeda to keep consumer business, looks outside Japan for selloffs instead: CEO
Fierce Pharma
Takeda
Japan
consumer health
Christophe Weber
Flag link:
Sun Pharma acquires two manufacturing plants in deal for Japanese company
Sun Pharma acquires two manufacturing plants in deal for Japanese company
Biopharma Dive
Sun Pharma
Japan
Pola Pharma
drug manufacturing
Flag link:
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Takeda
shareholders
Japan
M&A
Shire
Europe
Flag link:
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
J&J makes $2.1 billion offer to buy out Japan cosmetics firm Ci:z
CNBC
JNJ
M&A
Japan
Flag link:
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
Alnylam Submits NDA in Japan for Onpattro for Hereditary ATTR Amyloidosis
CP Wire
Alnylam
Patisiran
Onpattro
Japan
hATTR amyloidosis
Flag link:

Pages